✦ LIBER ✦

Recombinant hirudin as an antithrombotic drug: current status and future perspectives

✍ Scribed by Fareed, J.; Walenga, J.M.; Pifarre, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Current Status and

✍ Masahiko Chikuma; Takaji Sato; Seiji Komeda 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 15 KB 👁 2 views

Nanoparticles as contrast agents for in-

✍ Megan A. Hahn; Amit K. Singh; Parvesh Sharma; Scott C. Brown; Brij M. Moudgil 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 780 KB

PLK1 as an oncology target: current stat

✍ Campbell McInnes; Michael D. Wyatt 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 353 KB

Microneedle-Mediated Transdermal and Int

✍ Donnelly, Ryan F.; Singh, Thakur Raghu Raj; Morrow, Desmond I. J.; Woolfson, A. 📂 Article 📅 2012 🏛 John Wiley & Sons, Ltd ⚖ 199 KB

Neuropeptide Y receptors as targets for

✍ Eric Parker; Margaret Van Heek; Andrew Stamford 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Pharmacovigilance practice and risk cont

✍ Li Zhang; Jingbo Yan; Xinmin Liu; Zuguang Ye; Xiaohui Yang; Ronald Meyboom; Kelv 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 366 KB